Exicure Announces Filing of Notification of Late Filing on Form 12b-25
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exicure (Nasdaq: XCUR) filed a late-filing notification with the SEC for its quarterly report covering the three months ended September 30, 2026.
The company attributed the delay primarily to additional time needed to complete its review of the accounting for certain assets and liabilities. Exicure expects to file the Form 10-Q within the five-day extension period provided by Rule 12b-25 under the Securities Exchange Act of 1934. The notification was submitted on Form 12b-25.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Moderate pointQuarterly report delayed for the three months ended September 30, 2026, primarily pending additional asset-and-liability accounting review.
Key Figures
- Extension period
- 5 days
- Expected Form 10-Q filing under Rule 12b-25
Historical Context
-
Agreed to sell GPC-100 program assets for KRW 6.5 billion, subject to closing conditions.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
form 12b-25 regulatory
form 10-q regulatory
rule 12b-25 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR, the “Company”) announced today that it filed a Notification of Late Filing on Form 12b-25 with the Securities and Exchange Commission (the “SEC”) with respect to its Quarterly Report on Form 10-Q for the three months ended September 30, 2026 (the “Form 10-Q”).
The delay is primarily due to additional time required to complete the Company’s review of the accounting for certain of its assets and liabilities.
The Company expects to file the Form 10-Q within the five-day extension period provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended.
About Exicure, Inc.
Exicure, Inc. (Nasdaq: XCUR) has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value. In January 2025, it acquired a clinical-stage biotechnology company developing therapeutics for hematologic diseases. The Company’s lead program in development is being evaluated for its ability to improve stem cell mobilization in multiple myeloma, sickle cell disease, and in support of cell and gene therapy. For more information, visit www.exicuretx.com.
Cautionary Note Regarding Forward Looking Statements
Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, statements related to the Company’s review in connection with the Form 10-Q and the expected filing date of the Form 10-Q. Words such as “plans,” “expects,” “will,” “anticipates,” “continue,” “believes,” “may,” “intend,” “could,” and other words and terms of similar meaning and expression are intended to identify forward-looking statements, although not all forward-looking statements contain such terms. Forward-looking statements are based on management’s current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause the Company’s actual results to differ from those contained in the forward-looking statements, see the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 25, 2026, as updated by the Company’s subsequent filings with the SEC. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law.
Media Contact:
Exicure, Inc.
pr@exicuretx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.